SRPKIN-1 as an inhibitor against hepatitis B virus blocking the viral particle formation and the early step of the viral infection

Xiaofang Li(Hamamatsu University School of Medicine), Tetsuro Suzuki(National Institute of Infectious Diseases)
Antiviral Research
November 20, 2023
Cited by 6


Related Papers